“The evidence would suggest that perhaps we need to investigate this pathway and perhaps this drug in both Parkinson’s, ...

CervoMed (CRVO) will deliver an oral presentation providing detailed safety and efficacy results from its completed RewinD-LB Phase 2b clinical ...

Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds.

MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...

Other causes may include vascular dementia, Lewy body dementia, brain injuries, and certain underlying health conditions. Major neurocognitive disorder, also known as dementia, is a ...

The chronic myeloid leukemia drug nilotinib (Tasigna) improved biomarkers and cognitive outcomes in people with dementia with ...

Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and Alzheimer's disease but can be more difficult to diagnose. Lewy bodies ...

It’s a broad term that covers the effects on people of a number of different medical conditions, including Alzheimer’s disease, vascular dementia, the Lewy body dementias and more. The effects ...

"It's well known that sleep disturbances such as REM sleep behavior disorder can be early predictors of conditions including Lewy body dementia or Parkinson's disease, Isaacson said.Monitoring ...